Login / Signup

Integrating CAR-T cell therapy into the management of DLBCL: what we are learning.

Massimo MartinoFilippo Antonio CanaleGaetana PortoChiara VerduciGiovanna UtanoGiorgia PolicastroJessyca GermanòCaterina AlatiLudovica SantoroLucrezia ImbalzanoMartina Pitea
Published in: Expert opinion on biological therapy (2023)
This review aims to describe the current landscape of CAR-T cells in DLBCL, outline their outcomes and toxicities, and explain the outstanding questions that remain to be addressed.
Keyphrases
  • cell therapy
  • diffuse large b cell lymphoma
  • stem cells
  • mesenchymal stem cells
  • single cell
  • type diabetes
  • metabolic syndrome
  • bone marrow
  • adipose tissue
  • weight loss
  • insulin resistance